A curious feature of the new coronavirus is that it rarely causes severe symptoms in children. This new virus, which can be lethal in the elderly, spares the vast majority of young children.
Researchers and staff at the Duke Human Vaccine Institute and the Duke Regional Biocontainment Laboratory are working around the clock to develop therapies and a vaccine to combat COVID-19.
The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine as a preventive drug for the novel coronavirus.
Facing a critical shortage of N95 face masks that block the coronavirus, Duke Health research and clinical teams have confirmed a way to use existing methods to decontaminate the masks so they can be reused.
The multimillion-dollar cryo-electron microscope is able to “see” proteins in atomic level detail by taking hundreds of thousands of molecular images of a biological specimen and then classifying and averaging them with powerful software to create a 3D image, and ultimately, a model of the protein.
Duke University Hospital has joined the first national study to test a potential therapy for COVID-19, giving hospitalized adult patients with significant symptoms an option to participate.
Tips from three Duke experts about various ways panic affects our lives -- and what we can do to mitigate it.
Dr. Cathleen Colón-Emeric has older parents who live nearby. Here are some of her suggestions for navigating the new and urgent conversations and decisions facing many families, including her own.
Video featuring Duke University School of Medicine experts discussing the public health impact of the corona virus and Duke’s research related to COVID-19 and infectious diseases